AquaBounty Technologies (AQB) Expected to Announce Earnings on Thursday

AquaBounty Technologies (NASDAQ:AQB) is projected to post its results before the market opens on Thursday, March 26th. Analysts expect AquaBounty Technologies to post earnings of ($0.52) per share and revenue of $0.50 million for the quarter.

AquaBounty Technologies Trading Down 5.5%

NASDAQ AQB opened at $0.95 on Thursday. The stock has a market cap of $3.69 million, a PE ratio of -1.14 and a beta of 1.29. AquaBounty Technologies has a 12 month low of $0.50 and a 12 month high of $2.95. The company’s 50-day moving average price is $0.94 and its 200-day moving average price is $1.15.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of AquaBounty Technologies in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On AquaBounty Technologies

An institutional investor recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP bought a new position in AquaBounty Technologies, Inc. (NASDAQ:AQB) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned approximately 0.97% of AquaBounty Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). 8.92% of the stock is owned by hedge funds and other institutional investors.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.